Skip to main content
Watch Insiders
RPRXHealthcare

Royalty Pharma plc (RPRX) Insider Trading

In the last 90 days, 3 Royalty Pharma plc (RPRX) insiders reported no open-market purchases and 5 sales totaling $12,970,309. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 5, 2026Marshall UristEVP, Research & InvestmentsSale4,126$57.10$235,595
Sep 28, 2026Marshall UristEVP, Research & InvestmentsSale4,126$57.88$238,813
Sep 22, 2026Christopher HiteEVP & Chairman, PartneringSale100,000$58.53$5,853,100
Aug 18, 2026Christopher HiteEVP & Chairman, PartneringSale100,000$59.97$5,997,250
Aug 13, 2026Terrance P. CoyneEVP & CFOSale11,002$58.68$645,551
Jul 1, 2026Marshall UristEVP, Research & InvestmentsSale9,099$55.88$508,454
Jun 30, 2026Christopher HiteEVP & Chairman, PartneringSale130,000$56.50$7,345,468
Jun 24, 2026Marshall UristEVP, Research & InvestmentsSale9,098$55.18$502,067
Jun 23, 2026Christopher HiteEVP & Chairman, PartneringSale150,000$54.40$8,159,280
May 26, 2026Terrance P. CoyneEVP & CFOSale64,399$53.98$3,476,116
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

RPRX insider trading FAQ

Are RPRX insiders buying or selling?
Over the last 90 days, RPRX insiders were net sellers, reporting $0.00 of open-market purchases and $12,970,309 of sales.
When was the last RPRX insider purchase?
No open-market insider purchase of Royalty Pharma plc stock was reported in the last 90 days.
Where does RPRX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Royalty Pharma plc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.